Hutchens & Kramer Investment Management Group, LLC Eli Lilly & CO Transaction History

Hutchens & Kramer Investment Management Group, LLC

$162 Million
Q3 2024

A detailed history of Hutchens & Kramer Investment Management Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hutchens & Kramer Investment Management Group, LLC holds 12,433 shares of LLY stock, worth $9.74 Million. This represents 6.81% of its overall portfolio holdings.

Number of Shares

12,433

Previous 42,669 70.86%

Holding current value

$9.74 Million

Previous $38.6 Million 71.49%

% of portfolio

6.81%

Previous 22.55%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $23.3 Million - $29 Million	-30,236 Reduced 70.86%	12,433 $11 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $28,994 - $36,361	-40 Reduced 0.09%	42,669 $38.6 Million
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $713,601 - $954,697	-1,205 Reduced 2.74%	42,709 $33.2 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $160,182 - $188,834	-305 Reduced 0.69%	43,914 $25.6 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $247,779 - $341,601	570 Added 1.31%	44,219 $23.8 Million
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $14,029 - $18,759	-40 Reduced 0.09%	43,649 $20.5 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $59,019 - $69,315	-190 Reduced 0.43%	43,689 $15 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $163,347 - $190,332	508 Added 1.17%	43,879 $16.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $27,869 - $31,759	-94 Reduced 0.22%	43,371 $13.9 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $24,806 - $29,127	89 Added 0.21%	43,465 $14.1 Million
Q4 2021 May 16, 2022	BUY	$224.85 - $279.04 $9.75 Million - $12.1 Million	43,376 New	43,376 $12.4 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchens & Kramer Investment Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hutchens & Kramer Investment Management Group, LLC with notifications on news.

Account

Hutchens & Kramer Investment Management Group, LLC Eli Lilly & CO Transaction History